Ho Young Lee

Title: Ho Young Lee - Innovator in T-Cell Dependent Bispecific Antibodies

Introduction

Ho Young Lee is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of immunology, particularly in the development of methods for assaying T-cell dependent bispecific antibodies. His innovative work has implications for therapeutic applications in cancer treatment and other diseases.

Latest Patents

Ho Young Lee holds a patent titled "Methods for assaying T-cell dependent bispecific antibodies." This invention provides a cell-based assay for measuring T cell activation mediated by a T cell-dependent bispecific antibody (TDB). The assay is useful for detecting a TDB in a composition, quantitating the amount of TDB, determining the potency and specificity of a TDB, and assessing whether a population of cells expresses a target antigen. Compositions and kits related to this assay are also contemplated. He has 1 patent to his name.

Career Highlights

Throughout his career, Ho Young Lee has worked with leading companies in the biotechnology sector, including Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with some of the brightest minds in the industry and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Guoying Jiang and Pin Yee Wong. Their collaborative efforts have further advanced the research and development of bispecific antibodies.

Conclusion

Ho Young Lee's contributions to the field of immunology through his innovative patent and collaborations with leading companies highlight his role as a key inventor in the biotechnology industry. His work continues to pave the way for advancements in therapeutic applications.